VIB Vermögen AG

BATS-CHIXE:VIH1D Stock Report

Market Cap: €229.4m

VIB Vermögen Future Growth

Future criteria checks 0/6

VIB Vermögen's earnings are forecast to decline at 36.8% per annum while its annual revenue is expected to grow at 0.07% per year. EPS is expected to decline by 36.8% per annum. Return on equity is forecast to be 7% in 3 years.

Key information

-36.8%

Earnings growth rate

-36.8%

EPS growth rate

Real Estate earnings growth58.5%
Revenue growth rate0.07%
Future return on equity7.0%
Analyst coverage

Low

Last updated22 Aug 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

BATS-CHIXE:VIH1D - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261014970951
12/31/20259242111971
12/31/20248538151041
12/31/20231031307575N/A
9/30/20231051077373N/A
6/30/2023108847171N/A
3/31/202312876N/AN/AN/A
12/31/2022128546868N/A
9/30/202212641N/AN/AN/A
6/30/2022126497474N/A
3/31/2022106143N/AN/AN/A
12/31/2021102307575N/A
9/30/202110154N/AN/AN/A
6/30/202198536971N/A
3/31/20219671N/AN/AN/A
12/31/202094666465N/A
9/30/20209471N/AN/AN/A
6/30/202093676464N/A
3/31/20209264N/AN/AN/A
12/31/201991636969N/A
9/30/20199058N/AN/AN/A
6/30/201989606767N/A
3/31/20198859N/AN/AN/A
12/31/201887586161N/A
9/30/20188658N/AN/AN/A
6/30/201885536161N/A
3/31/20188551N/AN/AN/A
12/31/201784525959N/A
9/30/20178349N/AN/AN/A
6/30/20178250N/A57N/A
3/31/20178150N/AN/AN/A
12/31/20168047N/A58N/A
9/30/20167943N/AN/AN/A
6/30/20167844N/A56N/A
3/31/20167740N/AN/AN/A
12/31/20157540N/A54N/A
9/30/20157337N/AN/AN/A
6/30/20157232N/AN/AN/A
3/31/20157132N/AN/AN/A
12/31/20147031N/A48N/A
9/30/20146929N/AN/AN/A
6/30/20146828N/AN/AN/A
3/31/20146627N/AN/AN/A
12/31/20136527N/A48N/A
9/30/20136425N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: VIH1D's earnings are forecast to decline over the next 3 years (-36.8% per year).

Earnings vs Market: VIH1D's earnings are forecast to decline over the next 3 years (-36.8% per year).

High Growth Earnings: VIH1D's earnings are forecast to decline over the next 3 years.

Revenue vs Market: VIH1D's revenue (0.07% per year) is forecast to grow slower than the UK market (3.7% per year).

High Growth Revenue: VIH1D's revenue (0.07% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: VIH1D's Return on Equity is forecast to be low in 3 years time (7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y